Soliqua® Insulin Glargine / Lixisenatide 100 U - 33 mcg / mL Injection 3 mL

Name: Insulin
Brand: Soliqua®

SOLIQUA, PEN 100ML-33ML (5/CT)

McKesson #

1108280

Manufacturer #

00024576105

Brand

Soliqua®

Manufacturer

Sanofi Pasteur

Country of Origin

Unknown

Alternate Manufacturer Number

3607900

Application

Insulin

Container Type

Prefilled Injection Pen

Dosage Form

Injection

Generic Drug Code

42676

Generic Drug Name

Insulin Glargine / Lixisenatide

NDC Number

00024576105

Product Dating

McKesson Acceptable Dating: we will ship >= 90 days

Storage Requirements

Requires Refrigeration

Strength

100 U - 33 mcg / mL

Type

Subcutaneous

UNSPSC Code

51183610

Volume

3 mL

SOLIQUA 100/33 is delivered subcutaneously, via the SOLIQUA 100/33 SoloStar® pen, once daily
This starting dose provides 15 Units of Lantus® and 5 mcg of lixisenatide, a GLP-1 RA
One Unit of SOLIQUA 100/33 contains 1 Unit of Lantus® and 0.33 mcg of lixisenatide